§ Funding Round
Series B funding round for Eliem Therapeutics raising $60M in May 2021
Series B funding round for Eliem Therapeutics raising $60M in May 2021
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
Access Biotechnology | — | — |
| Angel | vasudev bailey | |
| Organization | — | |
Connecticut Innovations | — | — |
| Organization | — | |
| Organization | — | |
Nextech Invest | — | — |
| Organization | — | |
| Organization | — | |
Acorn Bioventures | — | — |
simon tateLEAD | Angel | simon tate |
| Organization | — | |
| Organization | — | |
| Organization | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$260M
Top Valuation
-
Eliem Therapeutics raised $60M in a Series B round.
The round was announced on 05/01/21.
The round was led by simon tate, RA Capital Management.
